|
1
|
Cugell DW and Kamp DW: Asbestos and the
pleura: a review. Chest. 125:1103–1117. 2004. View Article : Google Scholar
|
|
2
|
Tsao AS, Wistuba I, Roth JA and Kindler
HL: Malignant pleural mesothelioma. J Clin Oncol. 27:2081–2090.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Broaddus VC: Asbestos, the mesothelial
cell and malignancy: a matter of life or death. Am J Respir Cell
Mol Biol. 17:657–659. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morinaga K, Kishimoto T, Sakatani M, Akira
M, Yokoyama K and Sera Y: Asbestos-related lung cancer and
mesothelioma in Japan. Ind Health. 39:65–74. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dufresne A, Begin R, Churg A and Masse S:
Mineral fiber content of lungs in patients with mesothelioma
seeking compensation in Quebec. Am J Respir Crit Care Med.
153:711–718. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Britton M: The epidemiology of
mesothelioma. Semin Oncol. 29:18–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zellos L and Sugarbaker DJ: Current
surgical management of malignant pleural mesothelioma. Curr Oncol
Rep. 4:354–360. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gupta SC, Kim JH, Prasad S and Aggarwal
BB: Regulation of survival, proliferation, invasion, angiogenesis,
and metastasis of tumor cells through modulation of inflammatory
pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liou KT, Shen YC, Chen CF, Tsao CM and
Tsai SK: Honokiol protects rat brain from focal cerebral
ischemia-reperfusion injury by inhibiting neutrophil infiltration
and reactive oxygen species production. Brain Res. 992:159–166.
2003. View Article : Google Scholar
|
|
10
|
Bai X, Cerimele F, Ushio-Fukai M, et al:
Honokiol, a small molecular weight natural product, inhibits
angiogenesis in vitro and tumor growth in vivo. J Biol Chem.
278:35501–35507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen F, Wang T, Wu YF, et al: Honokiol: a
potent chemotherapy candidate for human colorectal carcinoma. World
J Gastroenterol. 10:3459–3463. 2004.PubMed/NCBI
|
|
12
|
Wolf I, O’Kelly J, Wakimoto N, et al:
Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth
of breast cancer through induction of apoptosis and cell cycle
arrest. Int J Oncol. 30:1529–1537. 2007.PubMed/NCBI
|
|
13
|
Sheu ML, Liu SH and Lan KH: Honokiol
induces calpain-mediated glucose-regulated protein-94 cleavage and
apoptosis in human gastric cancer cells and reduces tumor growth.
PLoS One. 2:e10962007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishitsuka K, Hideshima T, Hamasaki M, et
al: Honokiol overcomes conventional drug resistance in human
multiple myeloma by induction of caspase-dependent and -independent
apoptosis. Blood. 106:1794–1800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang SE, Hsieh MT, Tsai TH and Hsu SL:
Down-modulation of Bcl-XL, release of cytochrome c and sequential
activation of caspases during honokiol-induced apoptosis in human
squamous lung cancer CH27 cells. Biochem Pharmacol. 63:1641–1651.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shigemura K, Arbiser JL, Sun SY, et al:
Honokiol, a natural plant product, inhibits the bone metastatic
growth of human prostate cancer cells. Cancer. 109:1279–1289. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chu S and Ferro TJ: Sp1: regulation of
gene expression by phosphorylation. Gene. 348:1–11. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deniaud E, Baguet J, Mathieu AL, Pages G,
Marvel J and Leverrier Y: Overexpression of Sp1 transcription
factor induces apoptosis. Oncogene. 25:7096–7105. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li L and Davie JR: The role of Sp1 and Sp3
in normal and cancer cell biology. Ann Anat. 192:275–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jutooru I, Chadalapaka G, Sreevalsan S, et
al: Arsenic trioxide downregulates specificity protein (Sp)
transcription factors and inhibits bladder cancer cell and tumor
growth. Exp Cell Res. 316:2174–2188. 2010. View Article : Google Scholar
|
|
22
|
Mann J: Natural products in cancer
chemotherapy: past, present and future. Nat Rev Cancer. 2:143–148.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park EJ, Min HY, Chung HJ, et al:
Down-regulation of c-Src/EGFR-mediated signaling activation is
involved in the honokiol-induced cell cycle arrest and apoptosis in
MDA-MB-231 human breast cancer cells. Cancer Lett. 277:133–140.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang T, Chen F, Chen Z, et al: Honokiol
induces apoptosis through p53-independent pathway in human
colorectal cell line RKO. World J Gastroenterol. 10:2205–2208.
2004.PubMed/NCBI
|
|
25
|
Arora S, Bhardwaj A, Srivastava SK, et al:
Honokiol arrests cell cycle, induces apoptosis, and potentiates the
cytotoxic effect of gemcitabine in human pancreatic cancer cells.
PLoS One. 6:e215732011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ishikawa C, Arbiser JL and Mori N:
Honokiol induces cell cycle arrest and apoptosis via inhibition of
survival signals in adult T-cell leukemia. Biochim Biophys Acta.
1820:879–887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rajendran P, Li F, Shanmugam MK, et al:
Honokiol inhibits signal transducer and activator of
transcription-3 signaling, proliferation, and survival of
hepatocellular carcinoma cells via the protein tyrosine phosphatase
SHP-1. J Cell Physiol. 227:2184–2195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Riss TL and Moravec RA: Use of multiple
assay endpoints to investigate the effects of incubation time, dose
of toxin, and plating density in cell-based cytotoxicity assays.
Assay Drug Dev Technol. 2:51–62. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Huang W, Huang S, Du J and Huang C:
Screening of anti-cancer agent using zebrafish: comparison with the
MTT assay. Biochem Biophys Res Commun. 422:85–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chiefari E, Brunetti A, Arturi F, et al:
Increased expression of AP2 and Sp1 transcription factors in human
thyroid tumors: a role in NIS expression regulation? BMC Cancer.
2:352002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hosoi Y, Watanabe T, Nakagawa K, et al:
Up-regulation of DNA-dependent protein kinase activity and Sp1 in
colorectal cancer. Int J Oncol. 25:461–468. 2004.PubMed/NCBI
|
|
32
|
Wang L, Wei D, Huang S, et al:
Transcription factor Sp1 expression is a significant predictor of
survival in human gastric cancer. Clin Cancer Res. 9:6371–6380.
2003.PubMed/NCBI
|
|
33
|
Yao JC, Wang L, Wei D, et al: Association
between expression of transcription factor Sp1 and increased
vascular endothelial growth factor expression, advanced stage, and
poor survival in patients with resected gastric cancer. Clin Cancer
Res. 10:4109–4117. 2004. View Article : Google Scholar
|
|
34
|
Zannetti A, Del Vecchio S, Carriero MV, et
al: Coordinate up-regulation of Sp1 DNA-binding activity and
urokinase receptor expression in breast carcinoma. Cancer Res.
60:1546–1551. 2000.PubMed/NCBI
|
|
35
|
Davie JR, He S, Li L, et al: Nuclear
organization and chromatin dynamics - Sp1, Sp3 and histone
deacetylases. Adv Enzyme Regul. 48:189–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee KA, Lee YJ, Ban JO, et al: The
flavonoid resveratrol suppresses growth of human malignant pleural
mesothelioma cells through direct inhibition of specificity protein
1. Int J Mol Med. 30:21–27. 2012.
|
|
37
|
Culver C, Melvin A, Mudie S and Rocha S:
HIF-1α depletion results in SP1-mediated cell cycle disruption and
alters the cellular response to chemotherapeutic drugs. Cell Cycle.
10:1249–1260. 2011.
|
|
38
|
Blume SW, Snyder RC, Ray R, Thomas S,
Koller CA and Miller DM: Mithramycin inhibits SP1 binding and
selectively inhibits transcriptional activity of the dihydrofolate
reductase gene in vitro and in vivo. J Clin Invest. 88:1613–1621.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chintharlapalli S, Papineni S, Lei P,
Pathi S and Safe S: Betulinic acid inhibits colon cancer cell and
tumor growth and induces proteasome-dependent and -independent
downregulation of specificity proteins (Sp) transcription factors.
BMC Cancer. 11:3712011. View Article : Google Scholar
|
|
40
|
Pietrzak M and Puzianowska-Kuznicka M:
p53-dependent repression of the human MCL-1 gene encoding an
anti-apoptotic member of the BCL-2 family: the role of Sp1 and of
basic transcription factor binding sites in the MCL-1 promoter.
Biol Chem. 389:383–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tapias A, Ciudad CJ, Roninson IB and Noe
V: Regulation of Sp1 by cell cycle-related proteins. Cell Cycle.
7:2856–2867. 2008. View Article : Google Scholar : PubMed/NCBI
|
